1,229
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

PELA microspheres with encapsulated arginine–chitosan/pBMP-2 nanoparticles induce pBMP-2 controlled-release, transfected osteoblastic progenitor cells, and promoted osteogenic differentiation

, , , &
Pages 330-339 | Received 04 Dec 2015, Accepted 09 Feb 2016, Published online: 09 Mar 2016

References

  • Alex SM, Sharma CP. 2014. Enhanced intracellular uptake and endocytic pathway selection mediated by hemocompatible ornithine grafted chitosan polycation for gene delivery. Colloids Surf B Biointerfaces. 122:792–800.
  • Banerjee T, Mitra S, Kumar Singh A, Kumar Sharma R, Maitra A. 2002. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm. 243:93–105.
  • Cardarelli F, Serresi M, Bizzarri R, Giacca M, Beltram F. 2007. In vivo study of HIV-1 Tat arginine-rich motif unveils its transport properties. Mol Ther. 15:1313–1322.
  • Faensen B, Wildemann B, Hain C, Höhne J, Funke Y. 2011. Local application of BMP-2 specific plasmids in fibrin glue does not promote implant fixation. BMC Musculoskelet Disord. 12:163.
  • Gao Y, Xu Z, Chen S, Gu W, Chen L, Li Y. 2008. Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency. Int J Pharm. 359:241–246.
  • Hakki SS, Bozkurt BS, Hakki EE. 2010. Boron regulates mineralized tissue-associated proteins in osteoblasts (MC3T3-E1). J Trace Elem Med Biol. 24:243–250.
  • Hussein-Al-Ali SH, Arulselvan P, Fakurazi S, Hussein MZ, Dorniani D. 2014. Arginine-chitosan- and arginine-polyethylene glycol-conjugated superparamagnetic nanoparticles: preparation, cytotoxicity and controlled-release. J Biomater Appl. 29:186–198.
  • Ji Y, Xu GP, Zhang ZP, Xia JJ. 2010. BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering. Ann Biomed Eng. 38:632–639.
  • Jin H, Zhang K, Qiao C, Yuan A, Li D. 2014. Efficiently engineered cell sheet using a complex of polyethylenimine-alginate nanocomposites plus bone morphogenetic protein 2 gene to promote new bone formation. Int J Nanomedicine. 9:2179–2190.
  • Kang R, Ghivizzani SC, Muzzonigro TS, Herndon JH. 2000. The Marshall R. Urist Young Investigator Award. Orthopaedic applications of gene therapy. From concept to clinic. Clin Orthop Relat Res. 375:324–337.
  • Kaplan IM, Wadia JS, Dowdy SF. 2005. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release. 102:247–253.
  • Kim EC, Kim TH, Jung JH, Hong SO, Lee DW. 2014. Enhanced osteogenic differentiation of MC3T3-E1 on rhBMP-2-immobilized titanium via click reaction. Carbohydr Polym. 103:170–178.
  • Li X, Jin A, Duan Y, Min S. 2015a. Optimization of entrapping conditions to improve the release of BMP-2 from PELA carriers by response surface methodology. Biomed Mater. 10: 015002.
  • Li X, Yi W, Jin A, Duan Y, Min S. 2015b. Effects of sequentially released BMP-2 and BMP-7 from PELA microcapsule-based scaffolds on the bone regeneration. Am J Transl Res. 7:1417–1428.
  • Lin Z, Feng R, Li J, Meng Y, Yuan L. 2014a. Nuclear translocation of CBP/p300-interacting protein CITED1 induced by parathyroid hormone requires serine phosphorylation at position 79 in its 63-84 domain. Cell Signal. 26:2436–2445.
  • Lin Z, Wang JS, Lin L, Zhang J. 2014b. Effects of BMP2 and VEGF165 on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. Exp Ther Med. 7:625–629.
  • Liu Q, Wang W, Zhang L, Zhao L. 2014. Involvement of N-cadherin/β-catenin interaction in the micro/nanotopography induced indirect mechanotransduction. Biomaterials. 35:6206–6218.
  • Liu WG, Zhang JR, Cao ZQ, Xu FY, Yao KD. 2004. A chitosan-arginine conjugate as a novel anticoagulation biomaterial. J Mater Sci Mater Med. 15:1199–1203.
  • Liu Y, Kong M, Cheng XJ, Wang QQ. 2013. Self-assembled nanoparticles based on amphiphilic chitosan derivative and hyaluronic acid for gene delivery. Carbohydr Polym. 94:309–316.
  • Lu H, Dai Y, Lv L, Zhao H. 2014. Chitosan-graft-polyethylenimine/DNA nanoparticles as novel non-viral gene delivery vectors targeting osteoarthritis. PLoS One. 9:e84703.
  • Malakooty Poor E, Baghaban Eslaminejad M, Gheibi N, Bagheri F. 2014. Chitosan-pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells. Artif Cells Nanomed Biotechnol. 42:376–384.
  • Malhotra M, Tomaro-Duchesneau C, Saha S, Kahouli I, Prakash S. 2013. Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA. Int J Nanomedicine. 8:2041–2052.
  • Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY. 2001. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 70:399–421.
  • Nahaei M, Valizadeh H, Baradaran B, Nahaei MR. 2013. Preparation and characterization of chitosan/β-cyclodextrin nanoparticles containing plasmid DNA encoding interleukin-12. Drug Res. 63:7–12.
  • Nie H, Ho ML, Wang CK, Wang CH, Fu YC. 2009. BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice. Biomaterials. 30:892–901.
  • Nie H, Wang CH. 2007. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. J Control Release. 120:111–121.
  • Osawa K, Okubo Y, Nakao K, Koyama N, Bessho K. 2010. Osteoinduction by repeat plasmid injection of human bone morphogenetic protein-2. J Gene Med. 12:937–944.
  • Qiao C, Zhang K, Jin H, Miao L, Shi C, Liu X. 2013. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo. Int J Nanomedicine. 8:2985–2995.
  • Vasudevan P, Gokul RS, Sankar S. 2013. Synthesis and characterization of nonlinear optical L-arginine semi-oxalate single crystal. Spectrochim Acta A Mol Biomol Spectrosc. 106:210–215.
  • Wegman F, Bijenhof A, Schuijff L, Oner FC, Dhert WJ. 2011. Osteogenic differentiation as a result of BMP-2 plasmid DNA based gene therapy in vitro and in vivo. Eur Cell Mater. 21:230–242.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.